The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Share News (ABC)

  • There is currently no data for ABC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sunday newspaper round-up: Bank of England, Sturgeon, Melrose

Sun, 11th Jun 2023 14:36

(Sharecast News) - Experts believe that the Bank of England will have to jack up its base rate from 4.5% at present to 5.5% by the end of 2023 in order to tame stubbornly high inflation. It was that prospect that had already resulted in lenders and building societies to raise the cost of fixed-rate mortgages or to pull deals altogether, as HSBC did during the preceding week. Higher rates also have implications for the cost of servicing the country's debts, in turn eliminating the Chancellor's already limited headroom to push through tax cuts before the elections. - The Financial Mail on Sunday

Police looking into accusations of financial misconduct by the Scottish National Party have arrested one of its former leaders, Nicola Sturgeon. Sturgeon was one of three individuals arrested as part of Operation Branchform, which is investigating whether £600,000-worth of donations to the independence campaign had been misspent by the party. - Guardian

Melrose boss Simon Peckham made a staunch defence of the takeover outfit in an interview. The executive said predator firms like his were necessary in markets in order to restructure poorly-run corporations that would otherwise just carry on underperforming. But he derided criticism of the firm as slash and burn merchants. Quite the opposite, Melrose had pumped over £1bn into GKN Aerospace. There were about 12 months of hard work left in order to spruce it up, he added. Indeed, Melrose "lover buying businesses and seeing them get better". - The Financial Mail on Sunday

Jeb Smith - also known as "the most feared man in corporate America" - has UK biotech outfit Abcam in its sights. Starboard Value, the hedge fund run by Smith, has taken a roughly 2% stake in the antibody company. Last year, Abcam shelved plans for a London float, instead pursuing a listing on the US Nasdaq Exchange. In parallel, Abcam's founders, Jonathan Milner, is pushing to be reinstalled as executive chairman. On Monday he will send a note to investors arguing that only under his leadership can the company undo its "sustained financial underperformance and value destruction". A spokesman for the company however said that Milner's claim were without merit. - Sunday Times

More News
27 Oct 2021 08:48

Abcam completes earnings-accretive BioVision acquisition

(Sharecast News) - Science research tools company Abcam announced on Wednesday that it has completed its acquisition of BioVision from Boai NKY Medical Holdings, for total consideration of $340m.

Read more
30 Sep 2021 09:35

LONDON BROKER RATINGS: Keppler Cheuvreux raises Pearson to Hold

LONDON BROKER RATINGS: Keppler Cheuvreux raises Pearson to Hold

Read more
15 Sep 2021 09:39

LONDON BROKER RATINGS: HSBC lifts Compass to Buy; RBC cuts JTC

LONDON BROKER RATINGS: HSBC lifts Compass to Buy; RBC cuts JTC

Read more
13 Sep 2021 13:01

IN BRIEF: Abcam profit grows as lab activity and demand recover

IN BRIEF: Abcam profit grows as lab activity and demand recover

Read more
6 Sep 2021 15:58

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
1 Sep 2021 16:22

PRESS: IP Group's Oxford Nanopore set for London float soon - Reuters

PRESS: IP Group's Oxford Nanopore set for London float soon - Reuters

Read more
13 Aug 2021 14:45

EXECUTIVE CHANGES: Insig AI executive chair and Palace Capital CFO out

EXECUTIVE CHANGES: Insig AI executive chair and Palace Capital CFO out

Read more
2 Aug 2021 09:48

Abcam to buy BioVision for $340m

(Sharecast News) - Abcam said on Monday that it has agreed to buy California-based BioVision for $340m.

Read more
2 Aug 2021 08:55

Abcam to acquire Boai NKY subsidiary BioVision for USD340 million

Abcam to acquire Boai NKY subsidiary BioVision for USD340 million

Read more
2 Aug 2021 07:43

LONDON MARKET PRE-OPEN: Meggitt agrees to GBP6.3 billion takeover

LONDON MARKET PRE-OPEN: Meggitt agrees to GBP6.3 billion takeover

Read more
1 Jul 2021 13:17

Abcam trades in line with expectations as lab product demand limited

Abcam trades in line with expectations as lab product demand limited

Read more
24 Jun 2021 16:07

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
24 Jun 2021 16:03

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
23 Jun 2021 09:31

BROKER RATINGS: HSBC cuts Burberry; Deutsche raises Travis Perkins

BROKER RATINGS: HSBC cuts Burberry; Deutsche raises Travis Perkins

Read more
2 Jun 2021 10:54

Abcam confirms financial year-end date change to December 31

Abcam confirms financial year-end date change to December 31

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.